Condition: Neurodevelopmental Disorders · Congenital Cardiomyopathy · Sponsor: University Hospital, Lille
Congenital cardiopathy are frequent malformations (1/100 birth). The progress of surgery permit a survival rate at the adult age of more than 90%. The long terms consequences must be taken in account and the nerodevelopmental disorders are in first place (intelectual deficiency, autism spectrum disorders, or attention disorders) and presents in 30 to 60% of the patients (Calmant, 2015). The impact can be important on the scolarity, the studies, the professional activity and finaly on the quality of life of the patients becomming adults. The identification of the risk factors on surgery period should permit to propose the most adapted follow-up to the specifics needs of each patients. On the scientific plans, the identification of early markers on brain dammage on EEG should permit to better apprehend the physiopathologic mecanisms involved.
This description comes directly from the study's public registry record.
Sylvie NGUYEN THE TICH, MD,PhD · 0320445962 · sylvie.nguyenthetich@chu-lille.fr
Sylvie JORIOT, MD · 0320445962 · sylvie.joriot@chu-lille.fr
Always discuss trial participation with your own doctor first.
| CHU de LILLE | Lille, Hauts-de-France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05658965